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Abstract
The mode of action of trans-resveratrol, a promising lead compound for the development of
neuroprotective drugs, is unknown. Data from a functional genomics study were retrieved
with the aim to find differentially expressed genes that may be involved in the benefits pro-
vided by trans-resveratrol. Genes that showed a significantly different expression (p<0.05,
cut-off of a two-fold change) in mice fed with a control diet or a control diet containing trans-
resveratrol were different in cortex, heart and skeletal muscle. In neocortex, we identified 4
up-regulated (Strap, Pkp4, Rab2a, Cpne3) and 22 down-regulated (Actn1, Arf3, Atp6v01,
Atp1a3, Atp1b2, Cacng7, Crtc1, Dbn1, Dnm1, Epn1, Gfap, Hap, Mark41, Rab5b, Nrxn2,
Ogt, Palm, Ptprn2, Ptprs, Syn2, Timp2, Vamp2) genes upon trans-resveratrol consumption.
Network analysis of gene products provided evidence of plakophilin 4 up-regulation as a trig-
gering factor for down-regulation of events related to synaptic vesicle transport and neuro-
transmitter release via underexpression of dynamin1 and Vamp2 (synaptobrevin 2) as
node-gene drivers. Analysis by RT-qPCR of some of the selected genes in a glioma cell line
showed that dynamin 1 mRNA was down-regulated even in acute trans-resveratrol treat-
ments. Taken all together, these results give insight on the glial-neuronal networks involved
in the neuroprotective role of trans-resveratrol.
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Introduction
Phytochemicals are in the front line to combat oxidative stress, mainly in the central nervous
system (CNS), which loses detoxification potential upon aging. In fact, aging is the main risk
factor in the two most prevalent neurodegenerative diseases in Western societies with high life
expectances: Parkinson’s (PD) and Alzheimer’s (AD) [1]. Unlike AD [2], PD patients have effi-
cacious therapies that address symptoms but do not result in neuroprotection, i.e. they not
impede disease progression [3,4]. 3, 5, 40-trihydroxy-stilbene, commonly known as resveratrol,
is among the most promising natural compounds with neuroprotective potential. Interest in
resveratrol came from noticing that part of the benefits Mediterranean diet were due to con-
sumption of wine, which is considered the main natural source of the compound. The natural
molecule was first identified in 1939 by a Japanese researcher, Michio Takaoka, after extraction
and purification from a medicinal herb, Veratrum album var grandiflorum [5,6]. Resveratrol
naturally exists in cis- and trans-configurations although trans-resveratrol (RSV) seems to be
the most biologically active isomer.
Two courses of action are designed to assess neuroprotection of RSV, one, epidemiologi-
cally based, consists on longitudinal studies of cohorts drinking wine in a daily basis. Never-
theless, RSV intake in “chronic” but moderate consumption of wine is probably not enough to
boost innate antioxidant mechanisms. In this direction, a combination of different natural
products in daily diets [up to 337 polyphenols are reported in a French population of circa
5000 participants with a total intake of approximately 1 g/day; cohort SUpple´mentation en
VItamines et Mine´raux AntioXydants (SU.VI.MAX)], [7], may have an impact on reducing
oxidative stress. The second approach is to assess the effect of RSV on nerve cells as a dietary
supplement and at concentrations that are comparatively higher than those found in wine.
Special care in such studies has to be taken in converting doses tested in rodents to doses in
humans [8]. A placebo-controlled, double-blind trial has even showed that RSV administra-
tion to mild-to-moderate AD patients is safe and modifies some of the validated AD biomark-
ers [9].
The neuroprotective actions of RSV have been studied in both in vivo and in vitro models
of AD [reviewed in [10]]. The results in animal models have been always promising despite
the limited knowledge on how to afford neuroprotection and the limited knowledge of the
molecular basis of RSV benefits. The antioxidant potential of RSV does not seem the cause of
its beneficial effect as deduced from the trials on "antioxidant and Alzheimer’s" registered in
ClinicalTrials.gov a US-National Institutes of Health-dependent office. With the exception of
vitamin E, none of the tested compounds of this study (coenzyme Q, fish oil or an ultrafiltrate
of animal blood that has to be intravenously administered) led to positive results. The potential
benefit of vitamin E did not exceed the effect of the main drug prescribed to AD patients,
memantine (an allosteric modulator of NMDA receptors). In fact, despite its “antioxidant”
power, vitamin E may even be a pro-oxidant for plasma lipoproteins [11,12]. Results were
unfortunately more deceiving on testing antioxidants to combat PD as 24 trials gave negative
results. Parkinson’sUK (https://www.parkinsons.org.uk) indicates: “Excessive amounts of anti-
oxidant vitamin supplements can adversely affect your health and wellbeing, and may interfere
with your Parkinson's medication”. Based on the hypothesis of antioxidants as neuroprotective
agents, a further issue is the need for these compounds to reach the CNS with fairly intact anti-
oxidant capabilities. It is unlikely that RSV penetrates the brain with significant antioxidant
power. The aim of the present study was to analyze genomic data from experiments with
rodents taking RSV in their diet and to identify genes that may mediate the reported beneficial
effects of RSV in the CNS.
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Results
Effect of RSV in gene expression
The main objective of this work was to study whether RSV affects gene expression in the brain
and how this can be related with neuroprotection in neurodegenerative diseases. A previous
analysis was performed taking advantage of similar data available from experiments in two
other tissues, skeletal muscle and heart [13]. Therefore, our first aim was to analyze whether
the effect of RSV in gene expression impacted on the same genes in the three different tissues
(neocortex, skeletal muscle and heart). The analysis was conducted using GEO2R with default
settings (see Methods), which provided a list of 250 differentially expressed genes for each tis-
sue. An example of raw data for four of the genes differentially expressed upon RSV intake is
shown in Fig 1. Lists were compared and a Venn diagram was constructed, as shown in Fig 2.
Using a cut-off of change in gene expression of two-fold no gene could be found in common
as differentially expressed in all three tissues. The significance level of pairwise comparison
was 0.05 according to the Fisher test. Therefore, it appears that RSV affects the expression of
different genes in different tissues.
RSV and differential gene expression in the CNS
When comparing the expression in neocortex from mice taking or not RSV in their diet, we
selected those genes that were up or down by two-fold and with a p<0.05 (adjusted, Benjamini
Fig 1. Raw data for four different genes: Atp1b2 (A), Dnm1 (B), Rab1 (C) and Vamp2 (D). Each red bar represents, in
relative units (RU), the expression measurement from a sample. The five replicates correspond to five different animals
(under control or under RSV-containing diets). (source: http://www.ncbi.nlm.nih.gov/geo/geo2r/?acc=GSE11291).
https://doi.org/10.1371/journal.pone.0176067.g001
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& Hochberg -false discovery rate- test). Analysis of gene expression using GeneSpring pro-
vided a list of genes whose number varies according to the selected parameters (Table 1). The
list of the 149 genes selected according to the criteria of two-fold cut-off and p<0.05 is pro-
vided as S1 Table. The list of the 250 genes selected by GEO2R according to default options,
i.e. Benjamini & Hochberg false discovery rate adjustment to the p-values, auto-detect log
transformation and NBCI-generated platform annotation to display results and to the criteria
of higher statistical potency (lower p-values thus providing more confidence in the effect of
RSV) is provided as S2 Table. The R script is provided in S2 Text. Fold-change values from the
two lists are slightly different because list summarization by GeneSpring is performed combin-
ing intensity values from different probes of a given gene in the probe set, to get a simple
Fig 2. Venn diagram constructed with lists of differentially expressed genes corresponding to the
three tissues (neocortex, heart and muscle) as identified using the GEO2R tool. The lists of genes were
first curated as indicated in Material and Methods.
https://doi.org/10.1371/journal.pone.0176067.g002
Table 1. Number of differentially expressed genes detected by GeneSpring depending on p-value and absolute fold change (FC) values. Analysis
of data, from control- and RSV-enriched diet both in quintuplicates, were performed using moderated T-test, the multiple testing correction of Benjamini-Hoch-
berg and asymptotic p-value (adjusted) computation.
p all p < 0.05 p < 0.02 p < 0.01 p < 0.005 p < 0.001
FC all 45101 8684 6166 4729 3623 1782
FC > 1.1 19195 8684 6166 4729 3623 1782
FC > 1.5 1338 1275 1232 1192 1133 903
FC > 2.0 158 149 148 145 144 129
FC > 3.0 6 6 6 6 6 6
https://doi.org/10.1371/journal.pone.0176067.t001
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intensity value for each gene. The default list obtained by GEO2R ranks gene expression
according to the statistical significance (-increasing- P value) of the fold change calculated for
each individual probe. Hence, fold-changes in GEO2R do not correspond to the expression of
genes but to the expression of individual probes.
We used a Venn diagram to look for genes present in both lists (from GEO2R and Gene-
Spring analysis). Curating the list of coincident genes (see Methods), we selected 26 for further
study. As shown in Table 2, most genes (22 out of 26) were down-regulated in the neocortex of
animals treated with RSV. With these 26 candidates we used panther (www.pantherdb.org/) to
draw Gene Ontology bar charts based on three different criteria: biological process, cell locali-
zation and molecular function (Fig 3). It should be noted that the percentage of down-regu-
lated genes was even higher (91%) in the non-curated list.
Among molecular function, protein binding was the most represented group with 31% of
the genes, followed by catalytic activity (26%) and structural function (15%). With respect to
biological processes, cell communication (26%) was the most important biological process
Table 2. Selected differentially expressed genes.
Gene
Symbol
Gene Title FC-G2R* FC-GS* Expression
Strap Serine/threonine kinase receptor associated protein 1.653 3.105 Up
Pkp4 Plakophilin 4 1.579 2.166 Up
Rab2a Member RAS oncogene family 1.518 2.413 Up
Cpne3 Copine III 1.345a 2.167a Upa
Actn1 Actinin, alpha 1 0.422 0.496 Down
Arf3 ADP-ribosylation factor 3 0.418 0.456 Down
Atp6v01 ATPase, H+ transporting, lysosomal V0 subunit A1 0.512 0.489 Down
Atp1a3 ATPase, Na+/K+ transporting, alpha 3 polypeptide 0.213 0.210 Down
Atp1b2 ATPase, Na+/K+ transporting, beta 2 polypeptide 0.343 0.389 Down
Cacng7 Calcium channel, voltage-dependent, gamma subunit 7 0.365 0.409 Down
Crtc1 CREB regulated transcription coactivator 1 0.456 0.460 Down
Dbn1 Drebrin 1 0.296 0.355 Down
Dnm1 dynamin 1 0.305 0.344 Down
Epn1 Epsin 1 0.464 0.472 Down
Gfap Glial fibrillary acidic protein 0.475 0.472 Down
Hap1 Huntingtin-associated protein 1 0.490 0.475 Down
Mark4 MAP/microtubule affinity-regulating kinase 4 0.062 0.460 Down
Rab5b Member RAS oncogene family 1.518 0.484 Down
Nrxn2 Neurexin II 0.330 0.370 Down
Ogt O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine-polypeptide-N-
acetylglucosaminyl transferase
0.377 0.370 Down
Palm Paralemmin 0.438 0.494 Down
Ptprn2 Protein tyrosine phosphatase, receptor type, N polypeptide 2 0.375 0.393 Down
Ptprs Protein tyrosine phosphatase, receptor type, S 0.359 0.450 Down
Syn2 Synapsin II 0.464 0.471 Down
Timp2 Tissue inhibitor of metalloproteinase 2 0.436 0.442 Down
Vamp2 Vesicle-associated membrane protein 2 0.336 0.343 Down
* Resveratrol-enriched versus control diet. FC-G2R: Fold Change according with GEO2R. FC-G2R: Fold Change according with GeneSpring.
a Despite different FC values from GEO2R and GeneSpring analysis, the gene is upregulated.
https://doi.org/10.1371/journal.pone.0176067.t002
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followed by metabolism (16%) and localization (18%). Finally, regarding cell localization, the
majority of gene products were in intracellular organelles.
Noteworthy, further relevant information was obtained by using STRING (STRING CON-
SORTIUM 2016), a public available tool that allows the generation of functional protein associa-
tion networks. The resulting network, taking into account all genes displayed in Table 2, is
shown in Fig 4. Remarkably, the low protein-protein interaction enrichment p-value (2.27 e-29)
indicated significantly more interactions than expected from a random set of proteins of similar
size, drawn from the genome, meaning that the products of the identified genes are most likely
biologically connected. The following genes did not display connections with other genes: Ptprs,
Rab2a, Dbn1, Cpne3, Timp2, Palm, Cacng7, Strap and Gfap. Apart from a marginal but interest-
ing connection between Mark4 and Crtc1, all other genes were connected via two main nodes,
namely Dnm1 and Vamp2. These two genes were interrelated and, whereas Dnm1 establishes
direct links with Pkp4, Rab5b and Epn1, and indirect links with Ogt,Actn1 and Arf3, Vamp2
establishes direct links with Atp1a3, Syn2, Ptprn2, and indirect ones with Atp1b2 and Hap 1. For
comparison purposes a network constructed using the non-curated list is provided in S1 Fig.
When the STRING analysis was performed using the non-curated list, we basically found the
same main hubs, Dnm1 and Vamp2, although the number of non-connected genes was much
higher and this fact reinforces the appropriateness of list curation. However, in the case of
Dnm1 the connection through Epn1 was further enriched with Aes and Atp6v0a1; and in the
case of Vamp2, the interaction with Syn2 was further connected with an additional hub, Dlg4.
Fig 3. Gene Ontology bar charts for three different criteria: biological process (A), cell localization (B) and molecular function (C). The list of
differentially expressed genes after RSV diet in neocortex were classified by Gene Ontology (GO) and drawn using Panther (www.pantherdb.
org/)
https://doi.org/10.1371/journal.pone.0176067.g003
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The PPI enrichment p-value for this list was higher than the one obtained with the curated list,
2.73 e-09, but still showing that this network has significantly more interactions than expected
from random assignments using proteins of similar size drawn from the genome.
Effects of acute RSV treatment in glioma C6 cells
Neocortex is composed of a variety of neuronal and glial cell types. Therefore, the differential
expression of the 26 candidate genes may occur in different CNS cells. Based on the data of
RSV effect in neocortex and as neuronal cells of the adult mammal CNS are more refractory
than glial cells to early changes in gene expression [14–16] we treated a glial cell line, C6, either
in the absence (control group) or in the presence of 100 μM RSV for 24 h. Specific mRNA
expression for 5 genes selected from the list in Table 2, Atp1b2, Dnm1, Rab2a and Vamp2, was
Fig 4. Network analysis using STRING. The list of differentially expressed genes in neocortex after RSV diet was
subjected to Network analysis using the STRING software as described in Methods. Square interaction score was
set at medium confidence (0.4; scores range from highest, 0.9, to low, 0.15, confidence). Other selected parameters
were: average node degree: 1.12, local clustering coefficient: 0.32 and active interaction sources including: text
mining, experiments, databases, co-expression, neighborhood, gene fusion and co-occurrence. Moreover, no
restrictions were forced in the number of interactions to show. Overexpressed genes are shown within red
rectangles. The colors of the edges represent the different types of protein associations, either from known or
predicted interactions: from curated databases (blue), experimentally determined (magenta), text mining (green) and
co-expression (black).
https://doi.org/10.1371/journal.pone.0176067.g004
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determined by Real-Time qRT-PCR (see Methods). Dnm1 and Vamp2 were selected because
they were nodes having more edges in Fig 5. Atp1b2 was selected because genes related to
energy-homeostasis are very relevant in glia-neuron interactions, and Rab2a was selected
because it is similarly important for vesicular fusion and trafficking as Vamp2. The mRNA for
Syn2 was also analyzed as a control for a gene not expressed in glia (its mRNA was not detect-
able in glioma C6 cells). As seen in Fig 5, acute RSV treatment did not induce changes in the
expression of Rab2a or Vamp2, whereas it induced a non-statistically significant increase in
Atp1b2 and, remarkably, led to a statistically significant down-regulation of Dnm1.
Discussion
A first aim of this work was to compare the effect of RSV on gene expression in three different
tissues. Tissues came from the same animals, C57BL/6xC3H/He mice, which received equally
similar caging and environmental conditions. Moreover, the genomics methodology was iden-
tical and, therefore, the results are fully comparable. RSV affects gene expression in a different
way in heart, neocortex and skeletal muscle, i.e. the effect was tissue-specific. Also of interest is
highlighting that this differential effect in the three tissues does not cause major side effects
and, in fact, RSV is a safe compound that may be taken at high doses without significant phe-
notypic alterations. Safety in animals agrees with the safety of the compound shown in a clini-
cal trial involving mil-to-moderate AD patients [9].
The main objective of the present work was to take advantage of genomics data to under-
stand how consumption of RSV is affecting CNS functionality. No gross alterations in gene
expression were expected since RSV-consuming animals did not display any particular neural-
related phenotype (peripheral or central) [13]. Indeed, the expression of several genes was
affected but the fold change, i.e. the expression in RSV-taking animals versus the expression in
animals taking the standard diet was relatively small. In this regard, 22 out of the 26 selected
genes whose expression is significantly affected by the use of RSV are down-regulated. There-
fore, it seems that the reported beneficial effect of RSV in CNS alterations [see [17] for review]
correlates with simultaneous reduction of the expression of different genes. Network analysis
Fig 5. Gene expression evaluated by reverse transcription, quantitative real-time PCR (RT-qPCR) in
control and in 100 μM RSV-treated C6 glioma cells. mRNA samples isolated from cells incubated for 24 h
were analyzed by RT-qPCR using specific probes for Atp1b2, Vamp2, Rab2a, and Dnm1. β-actin mRNA was
used as control. Data are mean ± SEM of four independent experiments. * p < 0.05 according to Student’s t
test.
https://doi.org/10.1371/journal.pone.0176067.g005
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showed that among interconnected genes (under moderate stringent parameters) all but Pkp4
were down-regulated. The three main nodes in the network constituted by 14 genes (Fig 4)
were Pkp4 Dnm1 and Vamp2; pkp4 and Dnm1, and Dnm1 and Vamp2, which were connected
in a direct way (Fig 4). Overall it seems that up-regulation of Pkp4 drives the down-regulation
of Dnm1 and Vamp2, which in turn drives the down-regulation of the other 11 genes in the net-
work. This hypothesis is further supported by the fact that Pkp4 is the only upregulated gene in
the network, and by the finding that all genes directly connected to Pkp4 (Dnm1, Actn1 and
Ogt) are down-regulated. The product of Pkp4, plakophilin 4 or p0071, an armadillo/catenin
family member, is relevant for cytoskeletal organization [18] and seems to be expressed in both
neurons [19] and glia [20]. Dnm gene products, dynamins, are large GTPases that polymerize
and contribute to scission and fission of vesicles from membranes being their principal function
related to endocytosis and vesicle transport. In particular, Dnm1 is heavily expressed in brain
and also acts as microtubule-, and phospholipid-binding protein [21,22]. The product of
Vamp2, synaptobrevin-2, a member of the vesicle-associated membrane protein (VAMP)/
synaptobrevin family, is widely expressed in the CNS [23], interacts with synaptophysin and
regulates inter alia pre-synaptic vesicle traffic [24] and neuronal morphogenesis and the branch-
ing of axons [25]. In summary, the protein product of up-regulated Pkp4 and most of the down-
regulated genes in the network take part, directly or indirectly, in events related to the cytoskele-
ton and to the transport of subcellular components. Some of the functions of gene products in
Table 2 focus on the synapse, specifically in the mobilization of the presynaptic vesicles and the
fusion of those with the presynaptic membrane and the subsequent neurotransmitter release.
Regarding the potential benefits of RSV consumption in AD therapy, literature indicates that
this phytochemical affects in a neuroprotective mode three pathophysiological mechanisms of
the disease: it reduces i) the pathology caused by β-amyloid peptide [26–30], ii) oxidative stress
[31] and iii) neuroinflammation [32–34]. It should be also noted that RSV modulates the expres-
sion of genes involved in cytoskeletal structure and vesicular traffic in soma, neuronal axon/ram-
ifications and nerve terminals, including synaptic pruning, something that does not occur in
heart or muscle [35]. Importantly, our results do not favor antioxidant actions due to RSV. It is
unlikely that an antioxidant-behaving molecule mainly affects cytoskeleton structure and/or
vesicular traffic and synaptic events.
Three of the four genes that were upregulated, Rab2a, Strap and Cpne3, and 6 down-regu-
lated genes, Gfap, Ptprs, Dbn1, Timp2, Palm, Cacng7, do not appear interrelated in the con-
structed network. The lack of connections among these genes may reflect underscoring glial
genes due to the higher qualitative and quantitative research focused on neuronal genes. In
fact, the lack of interconnections in the case of Gfap, whose product is the glial fibrillary acidic
protein, i.e. a glial protein, together with the finding that Dnm1 is differentially expressed in
C6 cells treated with the phytochemical (Fig 5), suggest that glia could have a significant role in
mediating the effect of RSV. Furthermore, exosomes, which appear as important in brain glial-
neuronal networks [36] may be produced by glia in a process in which some of the differen-
tially expressed genes found in this study are involved. An example is copine 3, a product of
Cpn3, that in our opinion deserves attention in the CNS for being ubiquitous and for its role as
a calcium-dependent phospholipid-binding protein [37,38]. To our knowledge there are no
studies on Cpn3 expression and function in neurons or glia.
Our last aim was to identify any significant gene whose expression would vary after an
acute treatment with RSV. We hypothesized that acute changes in neuronal cultures would
not be as informative and significant as acute changes in glial cells. Neuronal plasticity result-
ing in neuroprotective or memory-enhancing properties requires time and involves a myriad
of glial-neuronal interactions [39]. In addition, any region in the CNS has more diversity in
neuronal than in glial cell types. Thus, the study of RSV-induced changes in a given neuronal
Resveratrol effects in neocortex gene expression
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cell type may not be correlated to other neuronal cell types present in the same CNS area. The
less specialized function of glial cells could serve to find an early event that may help to under-
stand how glia participates in the effects of RSV on CNS. Hence, we used a well-established C6
glioma cell line [40], which has characteristics of stem cells such as multi-lineage differentia-
tion and self-renewal [41]. Upon treatment with RSV, the expression of Dynamin 1 (Dnm1)
was changed but not for other genes (Fig 5) whose expression was determined in parallel. The
direction of the change was similar to that obtained upon chronic treatment in mice, i.e. the
treatment with RSV decreased Dnm1 mRNA levels. Since its discovery, cloning and release of
expression data, the enrichment of Dnm1 in CNS was attributed to neuronal expression. In our
control using a neuronal-specific gene we demonstrated that glioma cells express the Dnm1
gene and that its expression is affected by RSV, even in acute treatments. Of note is that another
functional genomics study indicates that Dnm1 is expressed in glia-derived cell lines (NCBI--
GEO, ref. GDS4296). In this sense, our RT-qPCR analyses indicate that glial Dnm1 should be
also taken into account to understand the overall mode of action of RSV in the CNS. Recent
studies in Drosophila melanogaster have taken advantage of temperature sensitive alleles of shi-
bire, whose product is a dynamin [42,43], to show that this glial protein is required for pro-
grammed axon pruning and stabilization of motor neuron branches during metamorphosis
[44,45]. Even if there are very few studies of dynamins in mammalian neural cells, the work of
Sakai et al. (2013) is remarkable as it shows that Dnm1 is expressed in microglia and regulates
the activity of voltage-gated ion channels [46]. Taken all these data together, it appears that the
role of dynamin 1 as a central node in the network of differentially expressed genes (Fig 4) may
be due to neuronal dynamin 1 even though the glial gene must also be taken into account.
Finally, our findings detect a decrease in the expression of CREB-regulated transcription
coactivator 1 (Crtc1) upon RSV consumption. This result suggests that the benefits on this
compound in diseases with cognition deficits might be by CREB-independent mechanisms.
On the one hand, it is well established that activation of CREB by phosphorylation leads to
synaptic plasticity and has memory-enhancing properties [47]. On the other hand, RSV may
revert the cognition impairment in chronic unpredictable stress conditions [48]. Taken
together, these results indicate that either memory-enhancer properties of CREB could be
independent of Crtc1 levels or chronic consumption of RSV exerts memory-enhancing effects
by a CREB/Crtc1-independent pathway. This latter hypothesis may fit with the beneficial
effects of RSV intake in PD models; in which such benefits are not associated to CREB activa-
tion [49–51]. As above mentioned our results do not favor, as reported elsewhere Lu et al.
(2008), neuroprotection against dopamine denervation in PD models due to antioxidant or
radical scavenging properties of the compound [52].
Despite limitations in this type of study, namely heterogeneity of cell type in neocortex, lim-
ited number of verified genes, usage of a glioma cell line that is different from real glial cells
present in the brain, it is tempting to speculate that RSV achieves a modulation of gene expres-
sion in the CNS that positively affects the life span and the functionality of nerve cells by
default mechanisms common to many of them. The products of the genes in Table 2 may
serve as a good starting point for the study of neuroprotective effects of RSV and the role of




Data were searched within the Gene Expression Omnibus (GEO) database under “GEO Data-
Sets” (https://www.ncbi.nlm.nih.gov/gds/) using as keywords: resveratrol and neocortex,
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selecting the only hit, i.e. the report by Barger et al., [13] with reference ID “GSE11291” (www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11291) which refers to a study where the design
consisted in feeding male (C57BL/6xC3H/He) F1 hybrid mice from 14 to 30 months of age
with either a control diet, a RSV-containing diet or a calorie restricted diet [13]. In the present
study, these data were analyzed using two different software tools: GEO2R and GeneSpring
(see “Data analysis tools” section). Retrieved data resulted from gene expression determined
using Affymetrix Mouse Genome 430 2.0 arrays, the specific platform used was GPL 1261,
containing probes for 45,000 genes. The profiling was assayed in samples from heart, skeletal
muscle and brain (neocortex) [13]. The control diet provided 84 kcal whereas the calorie
restricted one provided 63 kcal per mouse and week. RSV supplement (4.9 mg/Kg and day)
was given to animals taking the control diet. At 30 months of age, mice were sacrificed and tis-
sues were collected, flash-frozen in liquid nitrogen and stored at -80˚. Functional genomics
experiments were performed with these samples. For each condition, five replicates were pro-
cessed and the results for 4 genes are shown in Fig 1. Representative graphs show that the five
replicates have small standard deviation in both conditions, either from animals taking control
diet or from animals taking a RSV-containing diet.
Data analysis tools
GEO2R (www.ncbi.nlm.nih.gov/geo/info/geo2r.html) was used to perform comparisons on
GSE11291 data using GEO query and limma (Linear Models for Microarray Analysis) R pack-
ages from the Bioconductor project (www.bioconductor.org). The approach for false positive
detection is reported elsewhere [53]. It should be noted that GEO2R has a feature that checks
the character of values and, if required, it automatically performs a base 2 log transformation.
Raw results are shown in S1 Table, which lists 250 differentially expressed genes ranked by p-
value.
For comparison purposes we also used GeneSpring, which is a commercially-available soft-
ware package specially designed for analysis of microarray data [54]. By retrieving the geno-
mics data from control- and RSV-enriched diet both in quintuplicates (10 data files in total),
and by subsequent analysis using RMA (robust microarrays average) summarization algo-
rithm, baseline to median of control samples, a fold change cut-off higher than 2, moderated
T-test, the multiple testing correction of Benjamini-Hochberg and asymptotic <0.05 p-value
(adjusted) computation, we obtained 149 differentially expressed genes (S2 Table and S1
Text).
The raw lists of differentially expressed genes were manually curated. Genes not selected for
further studies were those whose physiological role is not known and/or whose cell/tissue
function is not established. First of all, genes whose products are suspected due to homology to
genes from other species (e.g. Drosophila) were discarded. Examples are: Ap2a1 (the gene
product is: adaptor-related protein complex 2, alpha 1 subunit), Actl6b (the gene product,
actin-like 6B, shares sequence homology with actin with no defined function) and Bicd2 (the
gene product is: bicaudal D homolog 2 of Drosophila) or Cnih2 (the gene product is: cornichon
homolog 2 of Drosophila).
Online tools for network construction
With a list of two-fold differentially expressed genes in samples from mice fed with/without
RSV, it is possible to look for functional relationships among the gene products. Connections
between gene products can be conceptualized as networks and the size and complexity of these
networks present a unique opportunity to look the transcriptome as something more than just
a static collection of data [55,56]. The “network view” of genes whose expression correlate in
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two given situations is increasingly being used in many areas of applied biology such as to
increase the statistical power in human genetics, to aid in drug discovery, to close gaps in met-
abolic enzyme knowledge and to predict phenotypes and gene functions [55,56].
We took advantage of online resources to integrate both known and predicted interactions
(Functional protein association networks). Interactions in STRING (Search Tool for the
Retrieval of Interacting Genes) are provided with confidence scores and this tool also offers
accessory information such as protein domains and 3D structures (with link to databases) if
available. The version of the program accessed via STRING DB website (http://string-db.org.
[55]) included > 2000 organisms, ranging from Bacteria and Archaea to humans. Selected
parameters were: average node degree: 1.12 and average local clustering coefficient: 0.32.
Medium confidence (0.4) was selected as square interaction score (scores range from highest,
0.9, to low, 0.15, confidence) and active interaction sources included were: text mining, experi-
ments, databases, co-expression, neighborhood, gene fusion and co-occurrence. No restric-
tions in the number of interactions to show.
Cell culture and RSV treatment
Rat C6 glioma cells were used to study gene expression as they have been previously used as
cell model for the treatment of RSV and have showed to be able to uptake this polyphenol [56].
Rat C6 glioma cells were obtained from the American Type Culture Collection (ATCC, USA).
The cell clone was originally developed from a N-nitrosomethylurea-induced rat glial tumor
[57]. Cells were grown, as described elsewhere [58], in DMEM (Dulbecco´s modified Eagle´s
medium) supplemented with 10% fetal calf serum, 2 mM L-glutamine, 1% non-essential
amino acids and antibiotics, in a humidified atmosphere of 95% air and 5% CO2 at 37˚C. Cells
in complete medium were incubated in the absence or in the presence of 100 μM RSV (Sigma
Aldrich, Madrid, Spain) for 24 h as previously used by other authors using the same cell line
[59]. At this concentration, RSV have previously showed neuroprotection against oxidative
stress [60]. Dilutions from a concentrated RSV solution in ethanol were used. The final con-
centration of ethanol in the samples (both control and RSV-treated) was 0.4% v:v)
Total RNA isolation and preparation of cDNA
Total RNA was extracted from C6 glioma cells using ABI 6100 Nucleic Acid PrepStation and
chemicals according to the manufacturer’s protocol (Applied Biosystems, Foster City, CA).
RNA purity was assessed by the 260:280 nm absorbance ratio; it was in the range 1.9–2.1. RNA
concentrations were determined from the absorbance at 260 nm. Total RNA was stored at
-80˚C. One microgram of total RNA was reverse transcribed using Applied Biosystems’ High-
Capacity cDNA Archive Kit according to the manufacturer’s protocol (Applied Biosystems,
Foster City, CA).
Quantitative real time PCR analysis
To assess relative gene expression in both control and RSV treated rat C6 glioma cells, quanti-
tative real time-PCR (RT-qPCR) analysis was performed with an Applied Biosystems Prism
7500 Fast Sequence Detection System, using TaqMan universal PCR master mix according to
the manufacturer’s specifications (Applied Biosystems, Foster City, CA). The TaqMan probes
and primers for Atp1b2 (assay ID: Rn00569739-m1), Vamp2 (assay ID: Rn01465442_m1),
Rab2a (assay ID: Rn00581858_m1), Dnm1 (assay ID: Rn00589865_m1) and β-actin (assay ID:
Rn00578826_m1) were assay-on-demand gene expression products (Applied Biosystems, Fos-
ter City, CA) as previously described [61]. β-actin was used as endogenous control for
normalization.
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Statistics and data analysis of PCR assays
Data are mean ± SEM of four independent experiments. Statistical data analysis was per-
formed using Student t-test with the GraphPad Prism 6 program (GraphPad Software, San
Diego, CA, USA). Differences between mean values were considered statistically significant at
p<0.05.
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